Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carrasco, Daniel
VP-315-201, NCT05188729: Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma	Completed	2	92	US	LTX-315 Part 1, VP-315, VP-315 Part 2, LTX-315	Verrica Pharmaceuticals Inc., Instat Clinical Research, HeartcoR Solutions, Myonex, Vial Health Technology, Inc	Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell, Cancer of the Skin, Carcinoma	04/24	04/24
Guerra, Alexandra
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carrasco, Daniel
VP-315-201, NCT05188729: Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma	Completed	2	92	US	LTX-315 Part 1, VP-315, VP-315 Part 2, LTX-315	Verrica Pharmaceuticals Inc., Instat Clinical Research, HeartcoR Solutions, Myonex, Vial Health Technology, Inc	Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell, Cancer of the Skin, Carcinoma	04/24	04/24
Guerra, Alexandra
No trials found